Life360, Inc.
Life360, Inc. (LIF) Financial Performance & Income Statement Overview
Review Life360, Inc. (LIF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Life360, Inc. (LIF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Life360, Inc. LIF financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $115.53M | $92.86M | $84.86M | $78.23M |
| Cost of Revenue | $30.02M | $22.85M | $21.24M | $18.21M |
| Gross Profit | $85.51M | $70.01M | $63.63M | $60.01M |
| Gross Profit Ratio | $0.74 | $0.75 | $0.75 | $0.77 |
| R&D Expenses | $29.79M | $29.01M | $27.01M | $27.26M |
| SG&A Expenses | $50.001M | $45.95M | $38.98M | $39.13M |
| Operating Expenses | $79.79M | $74.96M | $63.63M | $66.39M |
| Total Costs & Expenses | $109.81M | $97.82M | $87.23M | $84.61M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.80M | $2.48M | $2.45M | $2.38M |
| EBITDA | $8.52M | -$2.47M | $85000.00 | -$4.003M |
| EBITDA Ratio | $0.07 | -$0.03 | $0.001 | -$0.05 |
| Operating Income | $5.72M | -$4.95M | -$2.36M | -$6.38M |
| Operating Income Ratio | $0.05 | -$0.05 | -$0.03 | -$0.08 |
| Other Income/Expenses (Net) | $564000.00 | $7.91M | -$3.12M | -$2.004M |
| Income Before Tax | $6.28M | $2.96M | -$5.49M | -$8.38M |
| Income Before Tax Ratio | $0.05 | $0.03 | -$0.06 | -$0.11 |
| Income Tax Expense | -$2.22M | -$4.73M | $5.48M | $1.39M |
| Net Income | $8.50M | $7.69M | -$10.96M | -$9.78M |
| Net Income Ratio | $0.07 | $0.08 | -$0.13 | -$0.12 |
| EPS | $0.04 | $0.03 | -$0.05 | -$0.05 |
| Diluted EPS | $0.03 | $0.03 | -$0.05 | -$0.05 |
| Weighted Avg Shares Outstanding | $222.70M | $222.70M | $212.28M | $205.61M |
| Weighted Avg Shares Outstanding (Diluted) | $246.25M | $246.25M | $212.28M | $205.61M |
The company's financials show resilient growth, with revenue advancing from $78.23M in Q1 2024 to $115.53M in Q4 2024. Gross profit remained healthy with margins at 74% in Q4 2024 compared to 77% in Q1 2024. Operating income hit $5.72M last quarter, sustaining a consistent 5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $8.52M. Net income rose to $8.50M, while earnings per share reached $0.04. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan